NexImmune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NexImmune and other ETFs, options, and stocks.

About NEXI

NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. 

CEO
Kristi Jones
CEOKristi Jones
Employees
6
Employees6
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
2011
Founded2011
Employees
6
Employees6

NEXI Key Statistics

Market cap
4.76M
Market cap4.76M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
15.63K
Average volume15.63K
High today
$3.52
High today$3.52
Low today
$3.30
Low today$3.30
Open price
$3.41
Open price$3.41
Volume
10.19K
Volume10.19K
52 Week high
$28.69
52 Week high$28.69
52 Week low
$0.15
52 Week low$0.15
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.